Raymond James Financial Inc. Buys Shares of 74,165 Inozyme Pharma, Inc. (NASDAQ:INZY)
Raymond James Financial Inc. bought a new stake in Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 74,165 shares of the company’s stock, valued at approximately $205,000. Several other institutional investors and hedge funds have also […]
